TAD 600 is a prescription medicine containing 600 mg of reduced glutathione per vial. It is supplied as a lyophilized powder with a solvent for injection and is manufactured by Biomedica Foscama in Italy. A standard box contains ten vials of glutathione powder and ten ampoules of diluent.

Glutathione is a naturally occurring tripeptide composed of glutamic acid, cysteine, and glycine. It plays an important role in numerous biological processes, particularly those involving detoxification and antioxidant defense mechanisms that protect cells from oxidative damage.

TAD 600 is classified as an antidote and is approved in some regions for the prevention of neuropathy associated with certain chemotherapy treatments, including cisplatin-based therapies. It has also been studied for its role in supporting liver function and reducing the toxic effects of various substances.

The product is formulated as a powder and solvent for intramuscular or intravenous administration. Each reconstituted solution contains 150 mg/ml of glutathione and should be used according to professional medical guidance.

Key Benefits:

1. Provides 600 mg of reduced glutathione, a naturally occurring antioxidant involved in cellular protection.
2. Supports the body’s detoxification pathways and helps neutralize oxidative stress.
3. May assist liver function and cellular metabolism under medical supervision.
4. Used clinically as supportive therapy in specific medical treatments.
5. Convenient box packaging containing lyophilized vials and solvent for injection.

Product Specifications:

• Product Name: TAD 600 Glutathione
• Active Ingredient: Reduced Glutathione
• Strength: 600 mg
• Packaging: 1 box
• Dosage Form: Lyophilized powder and solvent for injection
• Administration: Intramuscular (IM) or intravenous (IV)
• Manufacturer: Biomedica Foscama, Italy